Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)
Others
Ratios

Pulse Biosciences (PLSE) Shares Outstanding (Weighted Average) (2020 - 2025)

Historic Shares Outstanding (Weighted Average) for Pulse Biosciences (PLSE) over the last 6 years, with Q3 2025 value amounting to $67.4 million.

  • Pulse Biosciences' Shares Outstanding (Weighted Average) rose 1034.78% to $67.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $67.4 million, marking a year-over-year increase of 1034.78%. This contributed to the annual value of $58.4 million for FY2024, which is 1741.36% up from last year.
  • According to the latest figures from Q3 2025, Pulse Biosciences' Shares Outstanding (Weighted Average) is $67.4 million, which was up 1034.78% from $67.3 million recorded in Q2 2025.
  • Pulse Biosciences' 5-year Shares Outstanding (Weighted Average) high stood at $67.4 million for Q3 2025, and its period low was $26.1 million during Q1 2021.
  • In the last 5 years, Pulse Biosciences' Shares Outstanding (Weighted Average) had a median value of $46.1 million in 2023 and averaged $45.7 million.
  • In the last 5 years, Pulse Biosciences' Shares Outstanding (Weighted Average) skyrocketed by 5303.84% in 2023 and then soared by 738.58% in 2024.
  • Quarter analysis of 5 years shows Pulse Biosciences' Shares Outstanding (Weighted Average) stood at $28.0 million in 2021, then rose by 21.35% to $33.9 million in 2022, then skyrocketed by 46.57% to $49.7 million in 2023, then grew by 17.41% to $58.4 million in 2024, then grew by 15.39% to $67.4 million in 2025.
  • Its Shares Outstanding (Weighted Average) stands at $67.4 million for Q3 2025, versus $67.3 million for Q2 2025 and $67.1 million for Q1 2025.